• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
GBT

GBT

Global Blood Therapeutics, Inc.

NASDAQHealthcareBiotechnologyUS

USD68.49

+0.01 (+0.01%)

Company Profile

CEO

Ted Love

IPO Date

2015-08-12

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$68.48

Prev. Close

$68.48

Day Low

$68.47

Day High

$68.49

52W Low

$21.65

52W High

$73.02

Volume

3.28M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

44.7%

Avg Negative

21.7%

Avg Neutral

33.8%

News Feed

GBT Provides Regulatory and Pipeline Updates in Sickle Cell Disease (SCD)

GlobeNewsWire·7/22/2021·↑ positive

New Data Supporting the Potential Use of Oxbryta® (voxelotor) in Children Ages 4 to 11 Years with Sickle Cell Disease Presented at European Hematology Association 2021 Virtual Congress

GlobeNewsWire·6/11/2021·↑ positive

GBT Announces Upcoming Data Presentations at European Hematology Association (EHA) 2021 Virtual Congress

GlobeNewsWire·5/12/2021·↑ positive

Global Blood Therapeutics: Increasing Specialization In SCD

Seeking Alpha·5/9/2021·↑ positive

Global Blood Therapeutics Q1 Earnings Miss Estimates On Disappointing Sales For Its Sickle-Cell Disease Drug

Benzinga·5/6/2021·↓ negative

Why Global Blood Therapeutics Stock Is Sinking Today

The Motley Fool·5/6/2021·↓ negative

Global Blood Therapeutics, Inc. (GBT) CEO Dr. Ted Love on Q1 2021 Results - Earnings Call Transcript

Seeking Alpha·5/5/2021·↓ negative

Global Blood Therapeutics (GBT) Reports Q1 Loss, Lags Revenue Estimates

Zacks Investment Research·5/5/2021·↑ positive

GBT Reports First Quarter 2021 Financial Results

GlobeNewsWire·5/5/2021·↑ positive

Global Blood Therapeutics' Sickle Cell Med Results In Rapid, Durable Improvements In Hemoglobin Levels Throughout 72 Weeks Of Treatment

Benzinga·4/8/2021·↑ positive